Literature DB >> 21665242

Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.

Christine Nyiraneza1, Anne Jouret-Mourin, Alex Kartheuser, Philippe Camby, Olivier Plomteux, Roger Detry, Karin Dahan, Christine Sempoux.   

Abstract

Although evidence suggests an inverse relationship between microsatellite instability and p53 alterations in colorectal cancer, no study has thoroughly examined the use of p53 immunohistochemistry in phenotyping colorectal cancers. We investigated the value of p53 immunohistochemistry in microsatellite instability-positive colorectal cancers prescreening and attempted to clarify the relationship between DNA mismatch repair system and p53 pathway. In a series of 104 consecutive colorectal cancers, we performed p53 immunohistochemistry, TP53 mutational analysis, DNA mismatch repair system efficiency evaluation (DNA mismatch repair system immunohistochemistry, microsatellite instability status, MLH1/MSH2 germ line, and BRAF, murine double minute 2, and p21 immunohistochemistry. Microsatellite instability high was observed in 25 of 104 colorectal cancers, with DNA mismatch repair system protein loss (24/25) and germ line (8/25) or BRAF mutations (8/25). p53 immunohistochemistry revealed 3 distinct patterns of expression: complete negative immunostaining associated with truncating TP53 mutations (P < .0001), diffuse overexpression associated with missense TP53 mutations (P < .0001), and restricted overexpression characterized by a limited number of homogenously scattered strongly positive tumor cells in 36.5% of colorectal cancers. This latest pattern was associated with wild-type TP53 and microsatellite instability high colorectal cancers (P < .0001) including all Lynch tumors (8/8), but its presence among 22% of DNA mismatch repair system-competent colorectal cancers decreased its positive predictive value (55.2% [95% confidence interval, 45%-65%]). It was also correlated with murine double minute 2 overexpression (P < .0001) and inversely with p21 loss (P = .0002), independently of microsatellite instability status. In conclusion, a restricted pattern of p53 overexpression is preferentially associated with microsatellite instability high phenotype and could, therefore, be of clinical use as signal for microsatellite instability analysis in a large-scale tumor screening. Its association with concomitant murine double minute 2 overexpression suggests an alternative mechanism of p53 pathway deregulation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665242     DOI: 10.1016/j.humpath.2010.06.021

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Hypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.

Authors:  Christine Nyiraneza; Christine Sempoux; Roger Detry; Alex Kartheuser; Karin Dahan
Journal:  Clin Epigenetics       Date:  2012-06-15       Impact factor: 6.551

2.  Biomarkers in precision therapy in colorectal cancer.

Authors:  Marlies S Reimers; Eliane C M Zeestraten; Peter J K Kuppen; Gerrit Jan Liefers; Cornelis J H van de Velde
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-08-23

3.  Defective autophagosome formation in p53-null colorectal cancer reinforces crocin-induced apoptosis.

Authors:  Amr Amin; Khuloud Bajbouj; Adrian Koch; Muktheshwar Gandesiri; Regine Schneider-Stock
Journal:  Int J Mol Sci       Date:  2015-01-09       Impact factor: 5.923

4.  Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis.

Authors:  Zhangjian Zhou; Hao Zhang; Jianguo Lai; Dongmei Diao; Wenhan Li; Chengxue Dang; Yongchun Song
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

5.  The Correlation of KRAS Gene Expression and P53 Immunoexpression in Colorectal Adenocarcinoma.

Authors:  Meike Rachmawati; Herry Yulianti; Bethy S Hernowo; Sri Suryanti; Indra Wijaya; Nur Rahadiani; Didik S Heriyanto; Irianiwati Irianiwati
Journal:  Open Access Maced J Med Sci       Date:  2019-06-30

6.  Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.

Authors:  Vahid Akbari; Marzieh Kallhor; Behrouz Mollashahi; Abolfazl Movafagh
Journal:  Asian Pac J Cancer Prev       Date:  2019-08-01

7.  Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Cheng Feng; Hai-Lin Zhang; Ang Zeng; Ming Bai; Xiao-Jun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-28       Impact factor: 8.886

8.  Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process.

Authors:  Timothy A Warren; Natasa Broit; Jacinta L Simmons; Carly J Pierce; Sharad Chawla; Duncan L J Lambie; Gary Quagliotto; Ian S Brown; Peter G Parsons; Benedict J Panizza; Glen M Boyle
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

9.  Loss of heterozygosity at the human leukocyte antigen locus in thymic epithelial tumors.

Authors:  Yuan Chen; Guojin Wang; Peng Zhang; Yimei Liu; Yuanyuan Yao; Hai Wang; Yuanguo Wang
Journal:  Thorac Cancer       Date:  2015-04-09       Impact factor: 3.500

10.  Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.

Authors:  Aru W Sudoyo; Antonius N Kurniawan; Gita D Kusumo; Teguh P Putra; Fritzie A Rexana; Muhammad Yunus; Akterono D Budiyati; Dicky Kurniawan; Andi Utama; Ahmad R Utomo
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.